Eli Lilly and Company and Hims & Hers Health, Inc. announced an agreement on November 6, 2026, to make Zepbound (tirzepatide) and Foundayo (orforglipron) available to eligible patients through the Hims & Hers platform at self-pay prices starting at $149 and $299 per month …
Senstar Technologies Corporation filed its third-quarter 2026 financial results on November 6, 2026, reporting record quarterly revenue of $13.1 million for the three months ended September 30, 2026.
Under Armour, Inc. filed its second-quarter fiscal 2027 earnings press release on November 6, 2026, reporting unaudited results for the three months ended September 30, 2026, including a 7 percent revenue decline and updated full-year guidance.
Calumet, Inc. filed its third-quarter 2026 earnings release on November 6, 2026, reporting net income of $273.3 million and continued debt reduction across its three operating segments for the period ended September 30, 2026.
Vistra Corp. (NYSE:VST) reported its third quarter 2026 financial results on November 6, 2026, disclosing GAAP net income of $1,140 million and Ongoing Operations Adjusted EBITDA of $2,378 million, while also raising its full-year 2026 guidance and initiating 2027 guidance ranges.
Tang Heng, executive vice president of NIP Group Inc., filed a Schedule 13D on November 6, 2026, disclosing beneficial ownership of 53,337,563 ordinary shares following the vesting of restricted shares on October 30, 2026.
Starwood Property Trust, Inc. (NYSE:STWD) released its third-quarter 2026 earnings press release on November 6, 2026, reporting results for the fiscal quarter ended September 30, 2026.
Applied Optoelectronics, Inc. filed an 8-K on November 6, 2026, disclosing that its Compensation Committee granted inducement equity awards covering 1,346 shares of common stock to three new employees, with a grant date of November 2, 2026.
Bausch Health Companies Inc. and its Salix Pharmaceuticals unit disclosed the presentation of a real-world research poster at The Liver Meeting 2026 in Denver, Colorado, on November 6, 2026, covering mortality and rehospitalization outcomes in patients hospitalized with severe alcohol-associated hepatitis.
Brookdale Senior Living Inc. (NYSE:BKD) released its third-quarter 2026 earnings results on November 6, 2026, reporting a narrowed net loss and double-digit Adjusted EBITDA growth alongside updated full-year 2026 guidance.